Vietnam Medi Pharm Expo 2018: connecting healthcare providers

Vietnam Medi Pharm Expo 2018 will be the place for domestic and foreign businesses to connect

Accordingly, the exhibition will be held from August 2-4, 2018 at Saigon Exhibition and Convention Center (SECC) at 799 Nguyen Van Linh Street, District 7, Ho Chi Minh City.

With the results achieved in previous years, Vietnam Medi Pharm Expo 2018 is expected to welcome about 350 domestic and foreign enterprises and 15,000 visitors, signifying an increase of 20 per cent in the volume of enterprises and nearly four times the visitor volume.

An annual event, the exhibition is an opportunity for both foreign and local companies to promote their products, and approach experts, professors, doctors, and pharmacists in the industry. Besides, it is an opportunity for pharmaceutical firms to look for partners to expand their operations as well as distribution channels.

According to statistics from the organisation board, in 2017, Vietnam Medi Pharm Expo welcomed 10,200 experts, 22 per cent of whom were foreigners and about 4,000 visitors, up 30 per cent on-year.

There will be even more enterprises and visitors than at Vietnam Medi Pharm Expo 2017

To promote the objectives of the exhibition, the organiser has been actively inviting domestic and foreign enterprises to participate in Vietnam Medi Pharm Expo in an effort to convey the message of "trade opportunities, expansion of investment cooperation in Vietnam" to foreign enterprises and partners.

The board of organization has been proudly saying that the number of participating enterprises has been steadily increasing in the last three years. Along with the 43 per cent increase in enterprise volume from the usual markets like Germany, Japan, Korea, Singapore, India, Malaysia, and Taiwan, the expo marks the participation of new countries and territories, namely Israel, Iran, Mongolia, Ukraine, Russia, and the US.

Besides, there has been a constant increase in the number of products on display, including medical equipment (55 per cent), pharmaceuticals (17 per cent), and pharmaceutical industry equipment (23 per cent) between 2015 and 2017.